Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 1975,
Authors: 5409,
Journals: 512,
Outer References: 13295,
Words: 3300
Collection span: 1980 - 2004
View: Overview. Sorted by NCR.
Page 4: 1 2 3 4 5 6 7
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
---|---|---|---|---|---|
901 | 7 | 12 | 1825 2003 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 16(2):123-129 Hadgraft J; Goosen C; du Plessis J; Flynn G Predicting the dermal absorption of thalidomide and its derivatives | 0 | 0 |
902 | 8 | 12 | 1914 2004 INTERNATIONAL JOURNAL OF DERMATOLOGY 43(9):682-684 Cunha PR; de Oliveira JR; Salles MJ; Jamora J; Bystryn JC Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy | 0 | 0 |
903 | 7 | 12 | 1950 2004 LEUKEMIA & LYMPHOMA 45(8):1711-1712 Montagut C; Bosch F; Villela L; Rosinol L; Blade J Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide | 0 | 0 |
904 | 2 | 11 | 123 1984 LANCET 2(8417):1424-1426 JENKINS JS; POWELL RJ; ALLEN BR; LITTLEWOOD SM; MAURICE PDL; SMITH NJ THALIDOMIDE IN SEVERE OROGENITAL ULCERATION | 25 | 35 |
905 | 7 | 11 | 212 1987 ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 64(3):289-292 EISENBUD L; HOROWITZ I; KAY B RECURRENT APHTHOUS STOMATITIS OF THE BEHCETS TYPE - SUCCESSFUL TREATMENT WITH THALIDOMIDE | 7 | 18 |
906 | 0 | 11 | 224 1988 ARCHIVES OF TOXICOLOGY 62(2-3):200-204 SCHMAHL HJ; NAU H; NEUBERT D THE ENANTIOMERS OF THE TERATOGENIC THALIDOMIDE ANALOG EM-12 .1. CHIRAL INVERSION AND PLASMA PHARMACOKINETICS IN THE MARMOSET MONKEY | 8 | 18 |
907 | 4 | 11 | 232 1988 FUNDAMENTAL & CLINICAL PHARMACOLOGY 2(6):493-497 DESCOTES J; TEDONE R; EVREUX JC ENHANCEMENT OF ANTIBODY-RESPONSE AND DELAYED-TYPE HYPERSENSITIVITY BY THALIDOMIDE IN MICE | 3 | 3 |
908 | 6 | 11 | 252 1989 BIOCHEMICAL SOCIETY TRANSACTIONS 17(1):114-115 LYNE C; GOWER DB RADIAL THIN-LAYER CHROMATOGRAPHIC AUTORADIOGRAPHIC SCANS OF STEROID-METABOLISM IN THE PRESENCE OF THALIDOMIDE | 0 | 1 |
909 | 2 | 11 | 305 1991 BRITISH MEDICAL JOURNAL 303(6814):1404-1405 HOOPER M USE OF THALIDOMIDE IN LEPROSY | 2 | 2 |
910 | 6 | 11 | 384 1994 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 199(2):455-460 NISHIMURA K; HASHIMOTO Y; IWASAKI S ENHANCEMENT OF PHORBOL ESTER-INDUCED PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA BY THALIDOMIDE | 27 | 44 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
911 | 4 | 11 | 480 1995 NATURE 375(6531):453-453 ASHBY J; TINWELL H IS THALIDOMIDE MUTAGENIC | 7 | 11 |
912 | 6 | 11 | 514 1996 BRITISH MEDICAL JOURNAL 313(7054):377-378 Powell RJ New roles for thalidomide | 18 | 24 |
913 | 10 | 11 | 570 1997 AMERICAN JOURNAL OF GASTROENTEROLOGY 92(1):169-170 Ball SC; Sepkowitz KA; Jacobs JL Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: Case report and review | 12 | 13 |
914 | 4 | 11 | 653 1997 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 17(1):R1-R2 Neubert D Never-ending tales of the mode of the teratogenic action of thalidomide | 3 | 5 |
915 | 8 | 11 | 739 1998 REVUE DE MEDECINE INTERNE 19(3):196-198 Lair G; Marie I; Cailleux N; Blot E; Boullie MC; Courville P; Lauret P; Levesque H; Courtois H Langerhans cell histiocytosis in adult patients: cutaneous and mucous localizations improving with thalidomide | 9 | 13 |
916 | 6 | 11 | 793 1999 CLINICAL NEUROPHYSIOLOGY 110(4):735-739 Sadoh DR; Hawk JLM; Panayiotopoulos CP F-chronodispersion in patients on thalidomide | 5 | 5 |
917 | 4 | 11 | 846 1999 NATURE 400(6743):419-420 Neubert R; Merker HT; Neubert D Developmental model for thalidomide action | 3 | 4 |
918 | 5 | 11 | 848 1999 NATURE MEDICINE 5(5):489-490 Hales BF Thalidomide on the comeback trail | 30 | 32 |
919 | 5 | 11 | 866 1999 SLEEP 22(1):113-115 Kanbayashi T; Shimizu T; Takahashi Y; Kitajima T; Takahashi K; Saito Y; Hishikawa Y Thalidomide increases both REM and stage 3-4 sleep in human adults: A preliminary study | 9 | 11 |
920 | 7 | 11 | 1281 2002 AIDS 16(17):2355-2356 Teo S; Noormohamed F; Youle M; Johnson M; Peters B; Stirling D; Thomas S Transient increase in plasma HIV-1 viral load and associated weight gain after thalidomide dosing | 1 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
921 | 4 | 11 | 1535 2002 OBSTETRICS AND GYNECOLOGY 99(1):125-128 Ances BM New concerns about thalidomide | 1 | 3 |
922 | 8 | 11 | 1550 2002 REVUE DE MEDECINE INTERNE 23(8):724-727 Gachon J; Grob JJ; Richard MA Thalidomide treatment leading thrombotic events: two cases | 3 | 4 |
923 | 8 | 11 | 1560 2003 ADAMANTIADES-BEHCET'S DISEASE 528:585-589 Sohn S; Lee ES; Lee SI; Kim YA; Kwon HJ; Bang D; Lei S Therapeutic effect of thalidomide through cytokine and chemokine regulation in herpes simplex virus-induced Behcet's disease-like animal model | 0 | 0 |
924 | 5 | 11 | 1673 2003 BRITISH JOURNAL OF DERMATOLOGY 148(5):1060-1061 Tjiu JW; Hsiao CH; Tsai TF Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment | 0 | 0 |
925 | 10 | 11 | 1783 2003 LEUKEMIA 17(9):1914-1915 Damaj G; Lefrere F; Delarue R; Varet B; Furman R; Hermine O Thalidomide therapy induces response in relapsed mantle cell lymphoma | 0 | 0 |
926 | 1 | 11 | 1797 2003 MEDICAL HYPOTHESES 60(4):513-514 Namazi MR The potential efficacy of thalidomide in the treatment of recalcitrant alopecia areata | 0 | 0 |
927 | 7 | 11 | 1815 2003 PRESSE MEDICALE 32(40):1894-1898 Brocvielle H; Muret P; Plenat E; Kantelip JP; Humbert P Management of a patient receiving thalidomide | 0 | 0 |
928 | 5 | 11 | 1849 2004 ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH 51(3):505-506 Pillemer SR; Leakan RA; Sankar V; Manny J; Baum BJ; Smith J; Chaudhry U; Fox PC; Radfar L; Ligier S; Brennan MT Prominent adverse effects of thalidomide in primary Sjogren's syndrome | 0 | 0 |
929 | 1 | 10 | 45 1982 DEVELOPMENT GROWTH & DIFFERENTIATION 24(2):217-222 MCBRIDE WG; STOKES PA; VARDY PH MATERNAL THALIDOMIDE TREATMENT AND CELL-DIVISION IN CULTURED RABBIT EMBRYOS - AUTOMATED IMAGE-ANALYSIS OF AUTORADIOGRAPHS | 2 | 2 |
930 | 1 | 10 | 49 1982 NATURWISSENSCHAFTEN 69(4):191-192 KOCHERBECKER U; KOCHER W; OCKENFELS H TERATOGENIC ACTIVITY OF A HYDROLYTIC THALIDOMIDE METABOLITE IN MICE | 3 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
931 | 0 | 10 | 161 1985 LANCET 1(8423):288-289 LEHNER T; SULLIVAN FM THALIDOMIDE, OROGENITAL ULCERS, AND THE RISK OF TERATOGENESIS | 1 | 3 |
932 | 3 | 10 | 188 1986 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 14(2):282-283 ARONSON IK; WEBER L; WEST D; BUYS C; REDER A; ANTEL J THALIDOMIDE AND LYMPHOCYTE FUNCTION | 6 | 6 |
933 | 1 | 10 | 219 1988 ARCHIV DER PHARMAZIE 321(6):371-373 KOCH HP; STEINACKER C IMPROVEMENT OF SOLUBILITY AND STABILITY OF THALIDOMIDE BY INCLUSION COMPLEXATION WITH CYCLODEXTRINS | 2 | 4 |
934 | 3 | 10 | 297 1990 TERATOLOGY 41(2):245-246 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 1 | 3 |
935 | 3 | 10 | 303 1991 BRITISH MEDICAL JOURNAL 303(6800):470-470 WATERS MFR USE OF THALIDOMIDE IN LEPROSY | 5 | 5 |
936 | 3 | 10 | 304 1991 BRITISH MEDICAL JOURNAL 303(6809):1062-1063 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 0 | 0 |
937 | 8 | 10 | 318 1992 ARCHIVES OF INTERNAL MEDICINE 152(5):1089-1090 BOUZA E; MUNOZ P; DIAZ MD; VICENTE T THALIDOMIDE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME | 3 | 6 |
938 | 4 | 10 | 325 1992 JOURNAL OF INFECTIOUS DISEASES 166(4):939-940 GEORGHIOU PR; ALLWORTH AM THALIDOMIDE IN PAINFUL AIDS-ASSOCIATED PROCTITIS | 11 | 21 |
939 | 7 | 10 | 350 1993 ARCHIVES OF INTERNAL MEDICINE 153(4):534-534 VICENTE T; ORTEGA A; MUNOZ P; DIAZ MD; BOUZA E INVITRO ACTIVITY OF THALIDOMIDE AGAINST MYCOBACTERIUM-AVIUM COMPLEX | 5 | 6 |
940 | 6 | 10 | 368 1993 MEDICINA CLINICA 100(14):557-557 GARCIAALBEA E; CABRERA F; TEJEIRO J; JIMENEZJIMENEZ FJ MIGRAINE AND THALIDOMIDE | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
941 | 3 | 10 | 369 1993 MEDICINA CLINICA 101(4):158-158 PIZARRO A; PINILLA J; GARCIATOBARUELA A THERAPY WITH THALIDOMIDE AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION | 0 | 1 |
942 | 4 | 10 | 383 1994 ARCHIVES OF TOXICOLOGY 68(3):203-205 KLUG S; FELIES A; STURJE H; NOGUEIRA AC; NEUBERT R; FRANKUS E EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES IN THE NONHUMAN PRIMATE CALLITHRIX-JACCHUS .5. LACK OF TERATOGENIC EFFECTS OF PHTHALIMIDOPHTHALIMIDE | 4 | 7 |
943 | 6 | 10 | 448 1995 CLINICAL BIOCHEMISTRY 28(4):467-470 LYON AW; DURAN G; RAISYS VA DETERMINATION OF THALIDOMIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - METHODOLOGICAL STRATEGY FOR CLINICAL-TRIALS | 6 | 7 |
944 | 5 | 10 | 451 1995 DIGESTIVE DISEASES AND SCIENCES 40(5):1147-1148 NAUM SM; MOLLOY PJ; KANIA RJ; MCGARR J; VANTHIEL DH USE OF THALIDOMIDE IN TREATMENT AND MAINTENANCE OF IDIOPATHIC ESOPHAGEAL ULCERS IN HIV+ INDIVIDUALS | 7 | 11 |
945 | 0 | 10 | 625 1997 JOURNAL OF PARENTERAL AND ENTERAL NUTRITION 21(4):233-234 Vromen A; Spira RM; Bercovier H; Berry E; Freund HR Pentoxifylline and thalidomide fail to reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat | 0 | 2 |
946 | 7 | 10 | 658 1998 AIDS PATIENT CARE AND STDS 12(12):903-906 Fu CS; Conteas CN; LaRiviere MJ Successful treatment of idiopathic colitis and proctitis using thalidomide in persons infected with human immunodeficiency virus | 2 | 3 |
947 | 7 | 10 | 690 1998 CLINICAL AND EXPERIMENTAL DERMATOLOGY 23(3):141-141 Georgala S; Katoulis AC; Hasapi V; Koumantaki-Mathioudaki E Thalidomide treatment for hypertrophic lupus erythematosus | 3 | 3 |
948 | 6 | 10 | 691 1998 CLINICAL AND EXPERIMENTAL DERMATOLOGY 23(5):233-235 Herranz P; Pizarro A; de Lucas R; Arribas JR; Garcia-Tobaruela A; Pena JM; Casado M Treatment of AIDS-associated prurigo nodularis with thalidomide | 4 | 5 |
949 | 9 | 10 | 695 1998 DRUG SAFETY 19(5):339-341 Smithells D Does thalidomide cause second generation birth defects? | 5 | 5 |
950 | 7 | 10 | 718 1998 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 39(2):293-295 Warren KJ; Nopper AJ; Crosby DL Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus | 7 | 9 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
951 | 4 | 10 | 792 1999 CLINICAL INFECTIOUS DISEASES 28(4):892-894 Ramirez-Amador VA; Esquivel-Pedraza L; Ponce-de-Leon S; Reyes-Teran G; Gonzalez-Guevara M; Ponce-de-Leon S; Sierra-Madero JG Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: A double-blind placebo-controlled clinical trial | 4 | 5 |
952 | 6 | 10 | 816 1999 INTERNATIONAL JOURNAL OF DERMATOLOGY 38(1):76-77 Pizarro A; Garcia-Tobaruela A; Herranz P; Pinilla J Thalidomide as an inhibitor of tumor necrosis factor-alpha production: a word of caution | 1 | 1 |
953 | 3 | 10 | 842 1999 LUPUS 8(3):248-249 Rua-Figueroa I; Erausquin C; Naranjo A; Carretero-Hernandez G; Rodriguez-Lozano C; De la Rosa P Pustuloderma during cutaneous lupus treatment with thalidomide | 3 | 5 |
954 | 4 | 10 | 1024 2000 MEDICINA-BUENOS AIRES 60:61-65 Politi PM Thalidomide. Clinical trials in cancer. | 1 | 1 |
955 | 0 | 10 | 1051 2000 SEMINARS IN HEMATOLOGY 37(1):22-25 Alexanian R; Weber D Thalidomide for resistant and relapsing myeloma | 23 | 27 |
956 | 3 | 10 | 1166 2001 CHILDS NERVOUS SYSTEM 17(6):370-372 Schoeman JF; Ravenscroft A; Hartzenberg HB Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess | 5 | 5 |
957 | 8 | 10 | 1205 2001 HAEMATOLOGICA 86(10):1108-1109 Camba L; Peccatori J; Pescarollo A; Tresoldi M; Corradini P; Bregni M Thalidomide and thrombosis in patients with multiple myeloma | 11 | 12 |
958 | 4 | 10 | 1228 2001 JOURNAL OF INFECTIOUS DISEASES 183(2):343-346 Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C; Natl Inst Allergy Infect Dis AIDS Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers | 1 | 3 |
959 | 2 | 10 | 1261 2001 POLISH JOURNAL OF PHARMACOLOGY 53(6):709-713 Dmoszynska A; Rolinski J; Bojarska-Junak A; Manko J; Jawniak D; Walter-Croneck A; Soroka-Wojtaszko M; Hus M Influence of thalidomide on Bcl(2) expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients | 0 | 0 |
960 | 3 | 10 | 1464 2002 HAEMATOLOGICA 87(8):884-886 Musto P; Falcone A; Sanpaolo G; Bisceglia M; Matera R; Carella AM Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes | 1 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
961 | 7 | 10 | 1510 2002 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 47(6):967-968 Boyd AS; King LE; Boyd AS Thalidomide-induced remission of lichen planopilaris | 0 | 0 |
962 | 3 | 10 | 1566 2003 AMERICAN JOURNAL OF HEMATOLOGY 74(3):205-207 Barton JC Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia | 0 | 0 |
963 | 1 | 10 | 1570 2003 AMERICAN JOURNAL OF MEDICINE 115(4):332-334 Staak JO; Glossmann JP; Esser JM; Diehl V; Mietz H; Josting A Thalidomide for systemic capillary leak syndrome | 0 | 0 |
964 | 4 | 10 | 1683 2003 BRITISH JOURNAL OF HAEMATOLOGY 123(2):305-308 Thompson MA; Witzig TE; Kumar S; Timm MM; Haug J; Fonseca R; Greipp PR; Lust JA; Rajkumar SV Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma | 2 | 4 |
965 | 5 | 10 | 1714 2003 DRUG METABOLISM AND DISPOSITION 31(8):1072-1072 Zhou SF CYP1A1-mediated activation of thalidomide and suppression of embryo fibroblast proliferation | 0 | 0 |
966 | 3 | 10 | 1725 2003 HAEMATOLOGICA 88(5):597-599 Patriarca F; Sperotto A; Prosdocimo S; Geromin A; Zaja F; Fanin R Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients | 0 | 0 |
967 | 4 | 10 | 1726 2003 HAEMATOLOGICA 88(8):958-960 Corso A; Lorenzi A; Zapposodi P; Invernizzi R; Vanelli L; Lazzarino M Early changes in bone marrow morphology induced by thalidomide in patients with refractory myeloma | 0 | 0 |
968 | 4 | 10 | 1727 2003 HAEMATOLOGICA 88(12):1432-1433 Offidani M; Marconi M; Corvotta L; Olivieri A; Catarini M; Leoni P Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study | 0 | 1 |
969 | 5 | 10 | 1729 2003 INTERNAL MEDICINE 42(7):605-608 Hayashi T; Yamaguchi I; Saitoh H; Takagi M; Nonaka Y; Nomura T Thalidomide treatment for immunoglobulin D multiple myeloma in a patient on chronic hemodialysis | 1 | 2 |
970 | 6 | 10 | 1768 2003 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 1(3):421-422 Barbui T; Falanga A Thalidomide and thrombosis in multiple myeloma | 2 | 2 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
971 | 6 | 10 | 1795 2003 LUPUS 12(9):723-724 Tektonidou MG; Vlachoyiannopoulos PG Antiphospholipid syndrome triggered by thalidomide in a patient with discoid lupus erythematosus | 0 | 0 |
972 | 6 | 10 | 1801 2003 NEUROLOGY 60(1):130-132 Gupta A; Cohen BH; Ruggieri P; Packer RJ; Phillips PC Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1 | 1 | 4 |
973 | 5 | 10 | 1882 2004 CEREBROVASCULAR DISEASES 18(2):175-177 Lenz RA; Saver J Venous sinus thrombosis in a patient taking thalidomide | 0 | 0 |
974 | 6 | 10 | 1911 2004 HAEMATOLOGICA 89(9):1141-1142 Galli M; Elice F; Crippa E; Comotti B; Rodeghiero F; Barbui T Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma | 0 | 0 |
975 | 7 | 10 | 1961 2004 MEDICINA CLINICA 122(15):595-596 Cistero B; Sala M; Soler A; Garcia N Thalidomide in the treatment of recurrent plasmocitomas in an HIV-infected patient | 0 | 0 |
976 | 7 | 10 | 1967 2004 NEUROLOGY 62(12):2288-2290 Briani C; Zara G; Rondinone R; Della Libera S; Ermani M; Ruggero S; Ghirardello A; Zampieri S; Doria A Thalidomide neurotoxicity - Prospective study in patients with lupus erythematosus | 1 | 1 |
977 | 7 | 10 | 1968 2004 NEUROLOGY 62(12):2291-2293 Cavaletti G; Beronio A; Reni L; Ghiglione E; Schenone A; Briani C; Zara G; Cocito D; Isoardo G; Ciaramitaro P; Plasmati R; Pastorelli F; Frigo M; Piatti M; Carpo M Thalidomide sensory neurotoxicity - A clinical and neurophysiologic study | 1 | 1 |
978 | 2 | 10 | 1974 2004 TRANSPLANTATION PROCEEDINGS 36(4):1018-1020 Chaves DNB; Petroianu A; Alberti LR; Pereira WA Effects of thalidomide, cyclosporine, and diclofenac on skin allograft survival in rabbits | 0 | 0 |
979 | 2 | 9 | 157 1985 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 13(2):304-305 MIYACHI Y; NIWA Y THALIDOMIDE AND OXYGEN INTERMEDIATES | 0 | 0 |
980 | 0 | 9 | 277 1990 GEBURTSHILFE UND FRAUENHEILKUNDE 50(11):899-900 SCHAEFER C; SPIELMANN H COCAINE AND PREGNANCY - SHADES OF THE THALIDOMIDE TRAGEDY | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
981 | 3 | 9 | 324 1992 JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS 582(1-2):211-216 ERIKSSON T; BJORKMAN S; FYGE A; EKBERG H DETERMINATION OF THALIDOMIDE IN PLASMA AND BLOOD BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - AVOIDING HYDROLYTIC DEGRADATION | 44 | 44 |
982 | 6 | 9 | 335 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(3):208-209 RYAN J; COLMAN J; PEDERSEN J; BENSON E THALIDOMIDE TO TREAT ESOPHAGEAL ULCER IN AIDS | 24 | 33 |
983 | 2 | 9 | 338 1992 TERATOLOGY 46(5):411-413 LIPSON AH THALIDOMIDE RETROSPECTIVE - WHAT DID THE CLINICAL TERATOLOGIST LEARN | 0 | 3 |
984 | 0 | 9 | 373 1993 PHARMAZIE 48(2):147-148 HOFENEDER M; KREBS G; SUTTER B; KOCH HP ACUTE TOXICITY OF THALIDOMIDE, TAGLUTIMIDE AND SUPIDIMIDE IN THE YEAST-TEST | 0 | 2 |
985 | 0 | 9 | 409 1994 JOURNAL OF CHROMATOGRAPHY A 666(1-2):235-240 KNOCHE B; BLASCHKE G INVESTIGATIONS ON THE IN-VITRO RACEMIZATION OF THALIDOMIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY | 20 | 31 |
986 | 7 | 9 | 521 1996 DERMATOLOGY 193(4):321-323 Bonnetblanc JM; Royer C; Bedane C Thalidomide and recurrent aphthous stomatitis: A follow-up study | 5 | 10 |
987 | 3 | 9 | 587 1997 CLINICAL AND EXPERIMENTAL DERMATOLOGY 22(6):297-299 Darvay A; Basarab T; Russell-Jones R Thalidomide-induced toxic pustuloderma | 4 | 8 |
988 | 3 | 9 | 636 1997 NATURE 385(6614):303-304 Wnendt S; Zwingenberger K Thalidomide's chirality | 9 | 16 |
989 | 2 | 9 | 731 1998 NATURE 396(6709):322-323 Tabin CJ A developmental model for thalidomide defects | 9 | 21 |
990 | 9 | 9 | 825 1999 JOURNAL OF CHROMATOGRAPHY B 734(2):203-210 Torano JS; Verbon A; Guchelaar HJ Quantitative determination of thalidomide in human serum with high-performance liquid chromatography using protein precipitation with trichloroacetic acid and ultraviolet detection | 8 | 8 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
991 | 3 | 9 | 871 2000 ACTA DERMATO-VENEREOLOGICA 80(1):24-25 Daly BM; Shuster S Antipruritic action of thalidomide | 3 | 9 |
992 | 4 | 9 | 985 2000 HAEMATOLOGICA 85(10):1111-1112 Pini M; Baraldi A; Pietrasanta D; Allione B; Depaoli L; Salvi F; Levis A Low-dose thalidomide in the treatment of refractory myeloma | 11 | 19 |
993 | 2 | 9 | 1204 2001 HAEMATOLOGICA 86(7):772-773 Pozzato G; Zorat F; Nascimben F; Comar C; Kikic F; Festini G Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia | 7 | 11 |
994 | 9 | 9 | 1226 2001 JOURNAL OF DERMATOLOGICAL TREATMENT 12(3):145-147 Thomson KF; Goodfield MJD Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus | 0 | 2 |
995 | 9 | 9 | 1407 2002 BRITISH JOURNAL OF OPHTHALMOLOGY 86(11):1303-1305 Eter N; Spitznas M DMSO mimics inhibitory effect of thalidomide on choriocapillary endothelial cell proliferation in culture | 0 | 0 |
996 | 1 | 9 | 1408 2002 BRITISH JOURNAL OF OPHTHALMOLOGY 86(11):1315-1316 Shuttleworth GN; Cook SD; Ropner JE Vanishing corneal epithelial crystals following thalidomide induced resolution of myeloma related paraproteinaemia | 0 | 0 |
997 | 1 | 9 | 1426 2002 CLINICAL CANCER RESEARCH 8(8):2750-2750 Go RS; Horstman AL Correspondence re: K. Neben et al, High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7 : 2675-2681, 2001. | 0 | 0 |
998 | 5 | 9 | 1559 2003 ACTA HAEMATOLOGICA 109(3):153-155 Tsiara S; Chaidos A; Kapsali H; Tzouvara E; Bourantas KL Thalidomide administration for the treatment of resistant plasma cell leukemia | 0 | 0 |
999 | 9 | 9 | 1578 2003 ANNALS OF ONCOLOGY 14(3):501-502 Trojan A; Chasse E; Gay B; Pichert G; Taverna C Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma | 2 | 2 |
1000 | 4 | 9 | 1672 2003 BRITISH JOURNAL OF DERMATOLOGY 148(3):601-602 Worm M; Kolde G Schnitzler's syndrome: successful treatment of two patients using thalidomide | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1001 | 4 | 9 | 1737 2003 JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 9(2):96-98 Ching DWT; McClintock A; Beswick F Successful treatment with low-dose thalidomide in a patient with both Behcet's disease and complex regional pain syndrome type I - Case report | 0 | 0 |
1002 | 0 | 8 | 2 1980 ARCHIVES OF DERMATOLOGICAL RESEARCH 269(3):275-280 FAURE M; THIVOLET J; GAUCHERAND M INHIBITION OF PMN LEUKOCYTES CHEMOTAXIS BY THALIDOMIDE | 59 | 70 |
1003 | 0 | 8 | 6 1981 ARCHIVES OF DERMATOLOGICAL RESEARCH 271(2):165-170 KNOP J; HAPPLE R; BONSMANN G; VAKILZADEH F; MACHER E TREATMENT OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS WITH THALIDOMIDE | 16 | 17 |
1004 | 0 | 8 | 34 1981 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 36(9-10):904-906 KOCHERBECKER U; KOCHER W; OCKENFELS H THALIDOMIDE-LIKE MALFORMATIONS CAUSED BY A TWEEN SURFACTANT IN MICE | 3 | 6 |
1005 | 1 | 8 | 43 1982 BRITISH JOURNAL OF DERMATOLOGY 107(1):83-86 NAAFS B; BAKKERS EJM; FLINTERMAN J; FABER WR THALIDOMIDE TREATMENT OF SUB-ACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS | 30 | 44 |
1006 | 1 | 8 | 68 1983 BRITISH JOURNAL OF DERMATOLOGY 108(4):461-466 KNOP J; BONSMANN G; HAPPLE R; LUDOLPH A; MATZ DR; MIFSUD EJ; MACHER E THALIDOMIDE IN THE TREATMENT OF 60 CASES OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS | 78 | 109 |
1007 | 0 | 8 | 148 1985 EXPERIMENTAL ANIMALS 34(3):295-302 MATSUBARA Y; MIKAMI T TERATOGENIC POTENTIALITY OF SINGLE DOSE OF THALIDOMIDE IN JW-NIBS RABBITS | 0 | 1 |
1008 | 2 | 8 | 164 1985 LANCET 2(8450):331-331 CRAWFORD CL THALIDOMIDE AND LEPROSY | 1 | 1 |
1009 | 2 | 8 | 177 1986 ARTHRITIS AND RHEUMATISM 29(10):1296-1296 SHEEHAN NJ THALIDOMIDE NEUROTOXICITY AND RHEUMATOID-ARTHRITIS | 2 | 2 |
1010 | 2 | 8 | 229 1988 BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY 95(7):717-719 MAOURIS PG; HIRSCH PJ PREGNANCY IN WOMEN WITH THALIDOMIDE-INDUCED DISABILITIES - CASE-REPORT AND A QUESTIONNAIRE STUDY | 0 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1011 | 0 | 8 | 244 1988 TERATOLOGY 38(3):203-215 LENZ W A SHORT HISTORY OF THALIDOMIDE EMBRYOPATHY | 39 | 70 |
1012 | 4 | 8 | 249 1988 TRANSPLANTATION PROCEEDINGS 20(2):226-228 VOGELSANG GB; WELLS MC; SANTOS GW; CHEN TL; HESS AD COMBINATION LOW-DOSE THALIDOMIDE AND CYCLOSPORINE PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN A RAT MISMATCHED MODEL | 14 | 16 |
1013 | 2 | 8 | 302 1991 BRITISH MEDICAL JOURNAL 302(6792):1603-1604 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 6 | 7 |
1014 | 0 | 8 | 431 1995 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 122(9):609-611 Safa G; Joly P; Boullie MC; Thomine E; Lauret P Treatment of 2 cases of Melkersson-Rosenthal syndrome with thalidomide | 3 | 8 |
1015 | 1 | 8 | 597 1997 DERMATOLOGY 195(4):359-361 Ferrandiz C; Carrascosa JM; Just M; Bielsa I; Ribera M Sequential combined therapy with thalidomide and narrow-band (TLO1) UVB in the treatment of prurigo nodularis | 9 | 12 |
1016 | 2 | 8 | 656 1998 AIDS 12(3):334-335 Di Fabio S; Trabattoni D; Geraci A; Ruzzante S; Panzini G; Fusi ML; Chiarotti F; Corrias F; Belli R; Verani P; Dalgleish A; Clerici M Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeys | 0 | 0 |
1017 | 3 | 8 | 754 1999 ARTHRITIS AND RHEUMATISM 42(3):580-581 Breban M; Gombert B; Amor B; Dougados M Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis | 16 | 53 |
1018 | 3 | 8 | 860 1999 PHARMACOLOGY & TOXICOLOGY 85(2):103-104 Huang PHT; McBride WG; Tuman WG Interaction of thalidomide with DNA of rabbit embryos: A possible explanation for its immunosuppressant and teratogenic effects | 3 | 3 |
1019 | 4 | 8 | 941 2000 BLOOD 96(12):3995-3996 Koc S; Leisenring W; Flowers MED; Anasetti C; Deeg HJ; Nash RA; Sanders JE; Witherspoon RP; Appelbaum FR; Storb R; Martin PJ Thalidomide for treatment of patients with chronic graft-versus-host disease | 14 | 23 |
1020 | 4 | 8 | 982 2000 GASTROENTEROLOGY 119(2):596-596 Fishman SJ; Feins NR; D'Amato RJ; Folkman J Thalidomide therapy for Crohn's disease | 5 | 12 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1021 | 8 | 8 | 1010 2000 JOURNAL OF INFECTIOUS DISEASES 182(2):639-639 Gori A; Rossi MC; Trabattoni D; Marchetti G; Fusi ML; Molteni C; Clerici M; Franzetti F Tumor necrosis factor-alpha increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection | 6 | 7 |
1022 | 2 | 8 | 1041 2000 ONCOLOGY-NEW YORK 14(12):29-32 Govindarajan R Irinotecan and thalidomide in metastatic colorectal cancer | 7 | 12 |
1023 | 3 | 8 | 1156 2001 BRITISH JOURNAL OF HAEMATOLOGY 115(2):484-485 Biagi JJ; Prince HM Thalidomide is effective for extramedullary relapse of multiple myeloma postallogeneic bone marrow transplantation | 1 | 1 |
1024 | 4 | 8 | 1255 2001 ONCOLOGY-NEW YORK 15(7):877-878 Govindarajan R Current status of thalidomide in the treatment of cancer - The Rajkumar article reviewed | 0 | 0 |
1025 | 2 | 8 | 1256 2001 ONCOLOGY-NEW YORK 15(7):878-879 Hwu WJ Current status of thalidomide in the treatment of cancer - The Rajkumar article reviewed | 0 | 0 |
1026 | 8 | 8 | 1325 2002 BLOOD 100(6):2272-2273 Cavo M; Zamagni E; Cellini C; Tosi P; Cangini D; Cini M; Valdre L; Palareti G; Masini L; Tura S; Baccarani M Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy | 11 | 15 |
1027 | 1 | 8 | 1465 2002 HAUTARZT 53(2):150-150 Ochsendorf F; Kaufman R Thalidomide in the treatment of cutaneous and systemic sarcoidosis | 0 | 0 |
1028 | 6 | 8 | 1498 2002 JOURNAL OF INVESTIGATIVE DERMATOLOGY 119(5):987-988 Gaspari A Thalidomide neurotoxicity in dermatological patients: The next "STEP'' | 1 | 2 |
1029 | 7 | 8 | 1520 2002 LEUKEMIA & LYMPHOMA 43(2):351-354 Johnston RE; Abdalla SH Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia | 7 | 9 |
1030 | 2 | 8 | 1558 2003 ACTA DERMATO-VENEREOLOGICA 83(4):302-303 Staumont-Salle D; Magro L; Piette F; Thomas P; Jouet JP; Catteau B Chronic graft-versus-host disease revealed by lichenoid vulvar lesions successfully treated with thalidomide | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1031 | 8 | 8 | 1700 2003 CLINICAL CANCER RESEARCH 9(14):5429-5429 Zhou SF Correspondence re: J. Lu et al., Thalidomide metabolites in mice and patients with multiple myeloma. Clin. Cancer Res., 9 : 1680-1688, 2003. | 0 | 0 |
1032 | 5 | 8 | 1781 2003 LEUKEMIA 17(6):1200-1202 Strupp C; Hildebrandt B; Germing U; Haas R; Gattermann N Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome | 0 | 1 |
1033 | 5 | 8 | 1782 2003 LEUKEMIA 17(8):1669-1670 Visani G; Mele A; Malagola M; Isidori A; Finelli C; Piccaluga PP Sequential combination of thalidomide and erythropoietin determines transfusion independence and disease control in idiopathic myelofibrosis previously insensitive to both drugs used as single agents | 1 | 1 |
1034 | 3 | 8 | 1784 2003 LEUKEMIA 17(10):2056-2057 Dalle JH; Leblond P; Decouvelaere A; Yakoub-Agha I; Preudhomme C; Nelken B; Mazingue F Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow tranplantation for T-ALL | 0 | 0 |
1035 | 7 | 8 | 1878 2004 CANCER 100(6):1186-1189 Pro B; Younes A; Albitar M; Dang NH; Samaniego F; Romaguera J; McLaughlin P; Hagemeister FB; Rodriguez MA; Clemons M; Cabanillas F Thalidomide for patients with recurrent lymphoma | 0 | 0 |
1036 | 0 | 7 | 12 1981 DERMATOLOGICA 163(2):145-150 SHESKIN J; GORODETSKY R; WEINREB A; LOEWINGER E IRON CONTENT OF SKIN BEFORE AND AFTER THALIDOMIDE TREATMENT OF LEPRA REACTION - A PRELIMINARY-REPORT | 0 | 5 |
1037 | 0 | 7 | 36 1982 ACTA DERMATO-VENEREOLOGICA 62(5):449-450 BAHMER FA; ZAUN H; LUSZPINSKI P THALIDOMIDE TREATMENT OF RECURRENT ERYTHEMA MULTIFORME | 19 | 25 |
1038 | 0 | 7 | 165 1985 LEPROSY REVIEW 56(1):35-39 GAD SM; SHANNON EJ; KROTOSKI WA; HASTINGS RC THALIDOMIDE INDUCES IMBALANCES IN LYMPHOCYTE-T SUB-POPULATIONS IN THE CIRCULATING BLOOD OF HEALTHY-MALES | 50 | 65 |
1039 | 1 | 7 | 200 1986 TRANSPLANTATION PROCEEDINGS 18(4):904-906 VOGELSANG GB; TAYLOR S; GORDON G; HESS AD THALIDOMIDE, A POTENT AGENT FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE | 19 | 27 |
1040 | 0 | 7 | 246 1988 TERATOLOGY 38(3):221-226 KELSEY FO THALIDOMIDE UPDATE - REGULATORY ASPECTS | 17 | 29 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1041 | 1 | 7 | 271 1990 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 8(4):427-427 HAMZA M BEHCETS-DISEASE, PALMOPLANTAR PUSTULOSIS AND HLA-B27 TREATMENT WITH THALIDOMIDE | 8 | 9 |
1042 | 0 | 7 | 273 1990 DICP-THE ANNALS OF PHARMACOTHERAPY 24(5):482-483 JEW LJ; MIDDLETON RK THALIDOMIDE IN ERYTHEMA-NODOSUM LEPROSUM | 0 | 0 |
1043 | 2 | 7 | 288 1990 MEDICAL JOURNAL OF AUSTRALIA 152(3):148-149 BROWN MA; FARRELL C; NEWTON P; CHILD RP THALIDOMIDE, PREGNANCY AND RENAL-FAILURE | 0 | 0 |
1044 | 0 | 7 | 314 1991 NEURO-OPHTHALMOLOGY 11(1):29-32 HUYGEN PLM; VANRIJN PM; VERHAGEN WIM; CREMERS CWRJ; THEUNISSEN EJJM SUBCORTICAL OPTOKINETIC RESPONSE IN A CASE OF THALIDOMIDE FETOPATHY | 0 | 1 |
1045 | 5 | 7 | 329 1992 LANCET 339(8792):549-550 BESSIS D; GUILLOT B; MONPOINT S; DANDURAND M; GUILHOU JJ THALIDOMIDE FOR SYSTEMIC LUPUS-ERYTHEMATOSUS | 27 | 31 |
1046 | 3 | 7 | 341 1992 TRANSPLANTATION PROCEEDINGS 24(6):2624-2625 OSTRAAT O; EKBERG H; SCHATZ H; RIESBECK K; ERIKSSON T THALIDOMIDE PROLONGS GRAFT-SURVIVAL IN RAT CARDIAC TRANSPLANTS | 9 | 9 |
1047 | 2 | 7 | 559 1996 REVISTA CLINICA ESPANOLA 196(4):270-271 Tercedor J; delaTorre ML; Rodenas JM Disseminated xanthoma with insipid diabetes: Therapeutic failure of thalidomide | 0 | 0 |
1048 | 5 | 7 | 682 1998 BONE MARROW TRANSPLANTATION 22(9):933-934 Sastry PSRK; Powles RL Thalidomide for chronic GVHD | 0 | 0 |
1049 | 1 | 7 | 947 2000 BRITISH JOURNAL OF HAEMATOLOGY 108(2):391-393 Kneller A; Raanani P; Hardan I; Avigdor A; Levi I; Berkowicz M; Ben-Bassat I Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drug | 53 | 75 |
1050 | 4 | 7 | 1065 2001 AMERICAN JOURNAL OF GASTROENTEROLOGY 96(4):1305-1306 Ginsburg PM; Hanan I; Ehrenpreis ED Treatment of severe esophageal Crohn's disease with thalidomide | 8 | 10 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1051 | 3 | 7 | 1070 2001 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 128(2):148-149 Esteve E; Legac E Deep vein thrombosis and pulmonary embolism in a patient with aphtosis treated with thalidomide | 4 | 4 |
1052 | 5 | 7 | 1267 2001 SCIENTIST 15(2):1-+ Lewis R The return of thalidomide | 0 | 1 |
1053 | 6 | 7 | 1406 2002 BRITISH JOURNAL OF HAEMATOLOGY 119(3):883-884 Gonzalez-Porras JR; Gonzalez M; Garcia-Sanz R; San Miguel JF Thalidomide in combination with cyclophosphamide and dexamethasone (ThaCyDex) is effective in soft-tissue plasmacytomas | 0 | 0 |
1054 | 4 | 7 | 1460 2002 HAEMATOLOGICA 87(3):327-328 Corso A; Lorenzi A; Orlandi E; Astori C; Mangiacavalli S; Lazzarino M Advantages of using thalidomide for the management of patients with refractory myeloma | 3 | 4 |
1055 | 2 | 7 | 1590 2003 ARCHIVES OF INTERNAL MEDICINE 163(12):1487-1488 Schwartzman R; Chevlen E; Bengtson K Thalidomide has activity in treating complex regional pain syndrome | 0 | 0 |
1056 | 4 | 7 | 1680 2003 BRITISH JOURNAL OF HAEMATOLOGY 122(1):159-160 Santos AB; Llamas P; Roman A; Prieto E; de Ona R; de Velasco JF; Tomas JF Evaluation of thrombophylic states in myeloma patients receiving thalidomide: A reasonable doubt | 2 | 2 |
1057 | 3 | 7 | 1802 2003 NEUROLOGY 60(5):877-878 Giannini F; Volpi N; Rossi S; Passero S; Fimiani M; Cerase A Thalidomide-induced neuropathy: a ganglionopathy? | 3 | 3 |
1058 | 5 | 7 | 1953 2004 LUPUS 13(6):481-482 Pagnoux C; Lutz-Zarrouk V; Michel M; Schaeffer A; Godeau B Cerebral venous thrombosis in a patient with antiphospholipid syndrome treated with thalidomide | 0 | 0 |
1059 | 2 | 6 | 84 1983 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 7(8-9):751-751 COUZIGOU P; DOUTRE MS; HOUDEE G; RICHARDMOLARD B; FLUERY B; AMOURETTI M; BEYLOT C; BERAUD C THALIDOMIDE IN THE TREATMENT OF BEHCETS SYNDROME | 0 | 9 |
1060 | 0 | 6 | 97 1983 TERATOLOGY 27(2):A29-A30 BECK SL PAUCITY OF POSTNATAL EFFECTS ON CD-1 MOUSE SKELETON OF PRENATAL EXPOSURE TO CAPTAN, THALIDOMIDE, CORTISONE, OR DIPHENYLHYDANTOIN | 0 | 3 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1061 | 1 | 6 | 125 1984 REVUE DU RHUMATISME 51(10):585-585 TREVES R; ARNAUD M; JACOB P; LUBEAU M; TABARAUD F; BURKI F; DESPROGESGOTTERON R DRAMATIC IMPROVEMENT IN THE ARTHRITIS OF BEHCETS-DISEASE FOLLOWING THE ADMINISTRATION OF THALIDOMIDE - A CASE-REPORT | 3 | 5 |
1062 | 2 | 6 | 217 1987 TRANSPLANTATION PROCEEDINGS 19(1):2658-2661 VOGELSANG GB; HESS AD; GORDON G; BRUNDRETTE R; SANTOS GW THALIDOMIDE INDUCTION OF BONE-MARROW TRANSPLANTATION TOLERANCE | 24 | 32 |
1063 | 0 | 6 | 233 1988 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 56(4):625-625 SALAFIA A; KHARKAR RD THALIDOMIDE AND EXFOLIATIVE DERMATITIS | 6 | 6 |
1064 | 2 | 6 | 236 1988 LANCET 1(8589):827-827 VOGELSANG GB; SANTOS GW; COLVIN OM; CHEN TL THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASE | 12 | 25 |
1065 | 3 | 6 | 254 1989 BONE MARROW TRANSPLANTATION 4(5):598-598 HEATON DC FAILURE OF THALIDOMIDE TO CONTROL BRONCHIOLITIS OBLITERANS POST BONE-MARROW TRANSPLANT | 1 | 3 |
1066 | 0 | 6 | 255 1989 BRITISH MEDICAL JOURNAL 298(6665):6-6 CHAMBERLAIN G THE OBSTETRIC PROBLEMS OF THE THALIDOMIDE CHILDREN | 0 | 0 |
1067 | 1 | 6 | 258 1989 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 13(1):104-104 PATEY O; CHARASZ N; ROUCAYROL AM; MALKIN JE; LAFAIX C THALIDOMIDE AND INTESTINAL INVOLVEMENT IN BEHCETS SYNDROME | 2 | 3 |
1068 | 0 | 6 | 278 1990 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 263(11):1467-1468 RANDALL T THALIDOMIDE BACK IN THE NEWS, BUT IN MORE FAVORABLE CIRCUMSTANCES | 7 | 21 |
1069 | 0 | 6 | 310 1991 JOURNAL OF LIQUID CHROMATOGRAPHY 14(4):667-673 ABOULENEIN HY; ISLAM MR DIRECT HPLC SEPARATION OF THALIDOMIDE ENANTIOMERS USING CELLULOSE TRIS-4-METHYLPHENYL BENZOATE CHIRAL STATIONARY PHASE | 9 | 17 |
1070 | 1 | 6 | 316 1992 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 119(4):281-283 BENSAID P; MACHET L; VAILLANT L; MACHET MC; SCOTTO B; LORETTE G ADULT LANGERHANS-CELL HISTIOCYTOSIS - REGRESSION OF PAROTID-GLAND INVOLVEMENT AFTER THALIDOMIDE TREATMENT | 13 | 18 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1071 | 1 | 6 | 317 1992 ANNALES DE MEDECINE INTERNE 143(7):479-480 LOUZIR B; OTHMANI S; GRITLI N; BEJI M; ZIDI B; MSADDEK F; BOUSSEMA E; BAHRI M ACUTE MYELOID-LEUKEMIA IN A BEHCETS-DISEASE PATIENT UNDER LONG-TERM THALIDOMIDE TREATMENT | 0 | 3 |
1072 | 4 | 6 | 319 1992 BRITISH JOURNAL OF DERMATOLOGY 126(1):92-93 MOISSON YF; JANIER M; CIVATTE J THALIDOMIDE FOR RECURRENT ERYTHEMA MULTIFORME | 9 | 12 |
1073 | 1 | 6 | 323 1992 INTERNATIONAL JOURNAL OF DERMATOLOGY 31(8):599-600 BERNAL JE; DURAN MM; LONDONO F; UMANA A CELLULAR IMMUNE EFFECTS OF THALIDOMIDE IN ACTINIC PRURIGO | 8 | 13 |
1074 | 5 | 6 | 332 1992 LANCET 339(8805):1362-1362 CARMICHAEL AJ; KNIGHT A THALIDOMIDE - A RESTRICTED ROLE | 3 | 5 |
1075 | 3 | 6 | 340 1992 TRANSPLANTATION PROCEEDINGS 24(6):2560-2561 ERIKSSON T; RIESBECK K; OSTRAAT O; EKBERG H; BJORKMAN S DRUG EXPOSURE AND FLOW-CYTOMETRY ANALYSES IN A THALIDOMIDE TREATMENT SCHEDULE THAT PROLONGS RAT CARDIAC GRAFT-SURVIVAL | 6 | 7 |
1076 | 3 | 6 | 367 1993 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 28(2):271-272 GHIGLIOTTI G; REPETTO T; FARRIS A; ROY MT; DEMARCHI R THALIDOMIDE - TREATMENT OF CHOICE FOR APHTHOUS ULCERS IN PATIENTS SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS | 31 | 39 |
1077 | 5 | 6 | 446 1995 CLINICAL AND EXPERIMENTAL DERMATOLOGY 20(1):85-85 MISERY L; PEGUETNAVARRO J; THIVOLET J; FAURE M; SCHMITT D; CLAUDY AL THALIDOMIDE DOES NOT AFFECT IN-VITRO MIXED SKIN CELL LYMPHOCYTE REACTIONS | 0 | 1 |
1078 | 4 | 6 | 449 1995 CLINICAL CHEMISTRY 41(8):1199-1199 HUUPPONEN R; PYYKKO K STABILITY OF THALIDOMIDE IN HUMAN PLASMA | 6 | 8 |
1079 | 3 | 6 | 471 1995 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 33(5):837-838 BERGER TG; HOFFMAN C; THIEBERG MD PRURIGO NODULARIS AND PHOTOSENSITIVITY IN AIDS - TREATMENT WITH THALIDOMIDE | 14 | 23 |
1080 | 0 | 6 | 560 1996 SLEEP 19(2):116-116 Kanbayashi T; Nishino S; Tafti M; Hishikawa Y; Dement WC; Mignot E Thalidomide, immune modulation and narcolepsy | 0 | 2 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1081 | 5 | 6 | 633 1997 M S-MEDECINE SCIENCES 13(4):595-596 Audit CO; Aimar C Thalidomide-induced teratogenesis. | 0 | 0 |
1082 | 2 | 6 | 943 2000 BONE MARROW TRANSPLANTATION 25(12):1319-1320 Zomas A; Anagnostopoulos N; Dimopoulos MA Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent | 18 | 32 |
1083 | 4 | 6 | 1033 2000 NEW ENGLAND JOURNAL OF MEDICINE 343(13):972-973 Rajkumar SV; Gertz MA; Witzig TE Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma. | 23 | 33 |
1084 | 6 | 6 | 1083 2001 ARTHRITIS AND RHEUMATISM 44(10):2456-2457 Lee L; Lawford R; McNeil HP The efficacy of thalidomide in severe refractory seronegative spondylarthropathy: comment on the letter by Breban et al | 2 | 5 |
1085 | 6 | 6 | 1194 2001 GASTROENTEROLOGY 120(6):1567-1568 Fox MR; Harris A Intractable insomnia after cessation of treatment with thalidomide | 3 | 3 |
1086 | 6 | 6 | 1236 2001 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 45(6):965-966 George SJ; Hsu S Lichen planopilaris treated with thalidomide | 3 | 6 |
1087 | 4 | 6 | 1296 2002 ANNALS OF ONCOLOGY 13(10):1636-1640 Grover JK; Uppal G; Raina V The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma | 3 | 4 |
1088 | 3 | 6 | 1320 2002 BLOOD 99(11):4249-4249 Zangari M Thalidomide and thromboembolism - Response | 0 | 0 |
1089 | 4 | 6 | 1399 2002 BRITISH JOURNAL OF DERMATOLOGY 146(6):1112-1113 Pouaha J; Martin S; Reichert-Penetrat S; Trechot P; Barbaud A; Schmutz JL Thalidomide and sexual dysfunction in men | 0 | 0 |
1090 | 0 | 6 | 1427 2002 CLINICAL CANCER RESEARCH 8(8):2751-2751 Neben K Correspondence re: K. Neben et al, High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7 : 2675-2681, 2001. Reply | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1091 | 6 | 6 | 1436 2002 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 127(15):818-818 Mensing H New indication for thalidomide? | 0 | 0 |
1092 | 1 | 6 | 1529 2002 MEDICAL JOURNAL OF AUSTRALIA 177(5):278-278 McBride W Thalidomide and cancer | 1 | 1 |
1093 | 1 | 6 | 1564 2003 AMERICAN JOURNAL OF GASTROENTEROLOGY 98(1):221-222 Shurafa M; Kamboj G Thalidomide for the treatment of bleeding angiodysplasias | 1 | 2 |
1094 | 5 | 6 | 1572 2003 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 130(4):489-489 Schmutz JL; Barbaud A; Trechot P Thalidomide and thrombosis | 0 | 0 |
1095 | 2 | 6 | 1664 2003 BONE MARROW TRANSPLANTATION 31(11):1065-1065 Pitini V; Arrigo C; Aloi G; Micali C; La Gattuta G Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT | 0 | 0 |
1096 | 6 | 6 | 1667 2003 BONE MARROW TRANSPLANTATION 32(3):343-343 Milone JH; Prates V; Bordone J; Napal J; Garcia C Response to single-agent thalidomide and eligibility to undergo autotransplant for patients with multiple myeloma refractory to VAD | 0 | 0 |
1097 | 5 | 6 | 1681 2003 BRITISH JOURNAL OF HAEMATOLOGY 122(1):160-161 Harris E; Behrens J; Samson D; Rahemtulla A; Russell NH; Byrne JL Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia | 2 | 3 |
1098 | 1 | 6 | 1718 2003 EUROPEAN JOURNAL OF HAEMATOLOGY 70(3):198-199 Vicari P; Ribas C; Sampaio M; Arantes AM; Yamamoto M; Reis JB; Segreto RA; Bordin JO; Colleoni GWB Can thalidomide be effective to treat plasma cell leptomeningeal infiltration? | 0 | 0 |
1099 | 3 | 6 | 1785 2003 LEUKEMIA 17(11):2237-2238 Mehta P; Hussein M Thalidomide as anti-inflammatory therapy for multiple myeloma | 0 | 0 |
1100 | 2 | 6 | 1786 2003 LEUKEMIA 17(11):2238-2238 Rajkumar SV; Witzig TE Thalidomide as anti-inflammatory therapy for multiple myeloma - Reply | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1101 | 1 | 6 | 1789 2003 LEUKEMIA & LYMPHOMA 44(6):1081-1082 Andretta C; Catalano L; Pace L; Fonti R; Annunziata G; Rotoli B 99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients | 0 | 1 |
1102 | 3 | 6 | 1832 2004 ACTA ONCOLOGICA 43(2):215-216 Ribas C; Colleoni G; Almeida M; Duch CR; Ohashi C; Segreto R; Silva MR Response of plasmacytomas to low-dose thalidomide in a patient with refractory multiple myeloma | 0 | 0 |
1103 | 2 | 6 | 1939 2004 JOURNAL OF THE ROYAL SOCIETY OF MEDICINE 97(9):443-443 de Savary N; Lee R; Vaidya B Severe hypothyroldism after thalidomide treatment | 0 | 0 |
1104 | 0 | 5 | 11 1981 DERMATOLOGICA 162(2):86-90 SHESKIN J; GORODETZKY R; LOEWINGER E; WEINREB A INVIVO MEASUREMENTS OF IRON, COPPER AND ZINC IN THE SKIN OF PRURIGO NODULARIS PATIENTS TREATED WITH THALIDOMIDE | 3 | 11 |
1105 | 0 | 5 | 50 1982 NOUVELLE PRESSE MEDICALE 11(14):1080-1081 HAMZA M; CHAFFAI M; BENAYED H TREATMENT OF BEHCETS-DISEASE WITH THALIDOMIDE | 9 | 15 |
1106 | 2 | 5 | 74 1983 BRITISH MEDICAL JOURNAL 287(6404):1550-1550 EFTHIMIOU J; SPIRO SG EFFECT OF THALIDOMIDE ON OROGENITAL ULCERATION | 2 | 2 |
1107 | 0 | 5 | 78 1983 CLINICAL AND EXPERIMENTAL DERMATOLOGY 8(2):208-209 LAURET P THALIDOMIDE AND THE MANAGEMENT OF LUPUS-ERYTHEMATOSUS | 0 | 1 |
1108 | 0 | 5 | 122 1984 LANCET 2(8396):205-206 [Anon] DEBENDOX IS NOT THALIDOMIDE | 0 | 0 |
1109 | 0 | 5 | 218 1988 ANAESTHESIA 43(7):613-614 MCCRORY JW ANESTHESIA AND THALIDOMIDE-RELATED ABNORMALITIES | 1 | 1 |
1110 | 4 | 5 | 226 1988 ARTHRITIS AND RHEUMATISM 31(1):145-146 GUTIERREZRODRIGUEZ O; STARUSTABACAL P; GUTIERREZMONTES O THALIDOMIDE-INDUCED NEUROPATHY IN RHEUMATOID-ARTHRITIS PATIENTS | 2 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1111 | 2 | 5 | 231 1988 DERMATOLOGICA 176(2):107-107 VIRABEN R; DUPRE A ERYTHEMA-NODOSUM FOLLOWING THALIDOMIDE THERAPY FOR BEHCET DISEASE | 1 | 5 |
1112 | 3 | 5 | 235 1988 LANCET 1(8581):359-359 SAURAT JH; CAMENZIND M; HELG C; CHAPUIS B THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION | 26 | 31 |
1113 | 3 | 5 | 256 1989 BRITISH MEDICAL JOURNAL 298(6671):432-432 YOULE M; CLARBOUR J; FARTHING C; CONNOLLY M; HAWKINS D; STAUGHTON R; GAZZARD B TREATMENT OF RESISTANT APHTHOUS ULCERATION WITH THALIDOMIDE IN PATIENTS POSITIVE FOR HIV ANTIBODY | 56 | 103 |
1114 | 1 | 5 | 328 1992 LANCET 339(8789):365-365 WINTER W; FRANKUS E THALIDOMIDE ENANTIOMERS | 12 | 18 |
1115 | 4 | 5 | 337 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(10):735-735 CRAWFORD CL THALIDOMIDE NEUROPATHY | 5 | 6 |
1116 | 4 | 5 | 353 1993 BONE MARROW TRANSPLANTATION 11(3):251-252 LOPEZ J; ULIBARRENA C; GARCIALARANA J; ODRIOZOLA J; DEOTEYZA JP; SASTRE JL; NAVARRO JL THALIDOMIDE AS THERAPY FOR INTESTINAL CHRONIC GVHD | 6 | 9 |
1117 | 5 | 5 | 391 1994 BRITISH MEDICAL JOURNAL 308(6941):1437-1438 CRAWFORD CL SAFETY OF THALIDOMIDE | 4 | 4 |
1118 | 3 | 5 | 397 1994 BRITISH MEDICAL JOURNAL 309(6966):1442-1442 TENCONI R; CLEMENTI M; NOTARI L; VASCO VRLO AMNIOTIC BAND SEQUENCE IN CHILD OF THALIDOMIDE VICTIM | 4 | 6 |
1119 | 2 | 5 | 414 1994 LANCET 343(8904):1041-1041 JONES GRN THALIDOMIDE - 35 YEARS ON AND STILL DEFORMING | 4 | 5 |
1120 | 3 | 5 | 415 1994 LANCET 344(8916):196-197 TEIXEIRA F; HOJYO MT; ARENAS R; VEGA ME; CORTES R; ORTIZ A; DOMINGUEZ L THALIDOMIDE - CAN IT CONTINUE TO BE USED | 4 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1121 | 1 | 5 | 430 1995 AIDS 9(6):658-659 SHARPSTONE D; ROWBOTTOM A; NELSON M; GAZZARD B THE TREATMENT OF MICROSPORIDIAL DIARRHEA WITH THALIDOMIDE | 14 | 34 |
1122 | 5 | 5 | 459 1995 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 19(1):128-129 SIRE S; FRAISSE P; REY D; JACQUEMIN C; KEMPF G; PARTISANI M; LANG JM EFFECTIVENESS OF THALIDOMIDE IN THE TREATMENT OF ESOPHAGEAL ULCERS IN AIDS | 2 | 2 |
1123 | 5 | 5 | 479 1995 MOLECULAR MEDICINE TODAY 1(5):210-210 STEWART A IS THALIDOMIDE A MUTAGEN | 0 | 0 |
1124 | 3 | 5 | 502 1996 ARCHIVES OF DISEASE IN CHILDHOOD 74(1):64-65 Soler RA; Migliorati C; vanWaes H; Nadal D Thalidomide treatment of mucosal ulcerations in HIV infection | 11 | 14 |
1125 | 1 | 5 | 523 1996 ENDOSCOPY 28(5):471-472 Louvel D; Musso S; Metivier S; Croizet O; Rouquet RM; Massip P; Escourrou J; Frexinos J Idiopathic esophageal ulceration associated with human immunodeficiency virus infection: Efficacy of thalidomide treatment | 0 | 1 |
1126 | 2 | 5 | 547 1996 LANCET 347(9006):974-974 Verberkmoes A; Boer K; Wertheim PME; Bronkhorst CM; Lange JMA Thalidomide for genital ulcer in HIV-positive woman | 4 | 9 |
1127 | 4 | 5 | 551 1996 NATURE MEDICINE 2(2):132-132 Crawford CL Thalidomide neuropathy | 1 | 1 |
1128 | 2 | 5 | 581 1997 BONE MARROW TRANSPLANTATION 19(1):95-96 Chen F; Tsang K; Liang R Thalidomide-responsive chronic pulmonary GVHD | 0 | 0 |
1129 | 5 | 5 | 590 1997 CLINICAL CHEMISTRY 43(6):1094-1095 Eriksson T; Bjorkman S Handling of blood samples for determination of thalidomide | 6 | 6 |
1130 | 3 | 5 | 591 1997 CLINICAL CHEMISTRY 43(6):1095-1096 Lyon AW; Raisys VA Handling of blood samples for determination of thalidomide - Respond | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1131 | 2 | 5 | 631 1997 LANCET 350(9089):1445-1446 Wettstein AR; Meagher AP Thalidomide in Crohn's disease | 35 | 53 |
1132 | 2 | 5 | 637 1997 NATURE 389(6647):118-118 Ashby J Thalidomide is not a mutagen | 3 | 4 |
1133 | 4 | 5 | 664 1998 ARCHIVES OF DERMATOLOGY 134(8):1045-1046 Rousseau L; Beylot-Barry M; Doutre MS; Beylot C Cutaneous sarcoidosis successfully treated with low doses of thalidomide | 12 | 25 |
1134 | 2 | 5 | 692 1998 CLINICAL INFECTIOUS DISEASES 26(1):184-185 Gori A; Franzetti F; Marchetti G; Rossi C; Fusi ML; Ruzzante S; Clerici M Clinical and immunological improvement in a patient who received thalidomide treatment for refractory Mycobacterium avium complex infection | 5 | 7 |
1135 | 1 | 5 | 722 1998 LANCET 351(9115):1591-1591 Smithells D Was the thalidomide tragedy preventable? | 0 | 0 |
1136 | 1 | 5 | 723 1998 LANCET 351(9115):1591-1591 Critchley EMR Was the thalidomide tragedy preventable? | 0 | 0 |
1137 | 5 | 5 | 725 1998 LANCET 352(9127):544-545 Stambe C; Wicks IP TNF alpha and response of treatment-resistant adult-onset Still's disease to thalidomide | 10 | 25 |
1138 | 3 | 5 | 740 1998 REVUE DE MEDECINE INTERNE 19(3):208-209 Grasland A; Pouchot J; Chaumaiziere D; Aitken G; Vinceneux P Effectiveness of thalidomide in cutaneous sarcoidosis | 3 | 4 |
1139 | 4 | 5 | 791 1999 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 17(3):393-393 de Wazieres B; Gil H; Vuitton DA; Dupond JL Treatment of recurrent oro-genital ulceration with low doses of thalidomide | 2 | 3 |
1140 | 2 | 5 | 798 1999 DERMATOLOGY 199(2):195-195 Bez C; Lodi G; Sardella A; Della Volpe A; Carrassi A Oral lichenoid lesions after thalidomide treatment | 5 | 5 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1141 | 4 | 5 | 837 1999 LANCET 353(9149):324-324 Klausner JD; Kaplan G; Haslett PAJ Thalidomide in toxic epidermal necrolysis | 7 | 8 |
1142 | 5 | 5 | 872 2000 AIDS 14(12):1859-1861 Gori A; Rossi MC; Marchetti G; Trabattoni D; Molteni C; Cogliati M; Bandera A; Clerici M; Franzetti F Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease | 5 | 7 |
1143 | 3 | 5 | 889 2000 ARCHIVES OF OPHTHALMOLOGY 118(1):135-136 Periman LM; Sires BS Full-thickness skin grafting of eyelids in a patient with generalized morphea taking thalidomide | 1 | 1 |
1144 | 1 | 5 | 1006 2000 JOURNAL OF CLINICAL ONCOLOGY 18(19):3453-3453 Cohen MH Thalidomide in the treatment of high-grade gliomas | 1 | 3 |
1145 | 4 | 5 | 1011 2000 JOURNAL OF INFECTIOUS DISEASES 182(2):640-640 Kaplan G Tumor necrosis factor-alpha increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection - Reply | 0 | 0 |
1146 | 2 | 5 | 1017 2000 LANCET 356(9229):566-567 Govindarajan R; Heaton KM; Broadwater R; Zeitlin A; Lang NP; Hauer-Jensen M Effect of thalidomide on gastrointestinal toxic effects of irinotecan | 21 | 30 |
1147 | 4 | 5 | 1027 2000 MUSCLE & NERVE 23(8):1301-1302 Rao DG; Kane NM; Oware A Thalidomide neuropathy: Role of F-wave monitoring | 5 | 5 |
1148 | 3 | 5 | 1078 2001 ARCHIVES OF INTERNAL MEDICINE 161(20):2502-2503 Rajkumar SV; Fonseca R; Witzig TE Complete resolution of reflex sympathetic dystrophy with thalidomide treatment | 3 | 4 |
1149 | 3 | 5 | 1096 2001 BLOOD 98(5):1614-1615 Zangari M; Anaissie E; Barlogie B; Badros A; Desikan R; Gopal AV; Morris C; Toor A; Siegel E; Fink L; Tricot G Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy | 63 | 94 |
1150 | 1 | 5 | 1220 2001 JOURNAL OF CHEMICAL EDUCATION 78(6):759-761 Bennett N; Cornely K Thalidomide makes a comeback: A case discussion exercise that integrates biochemistry and organic chemistry | 0 | 3 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1151 | 0 | 5 | 1237 2001 LANCET ONCOLOGY 2(10):634-635 Hwu WJ; Raizer J; Panageas KS; Lis E Treatment of metastatic melanoma in the brain with temozolomide and thalidomide | 3 | 7 |
1152 | 5 | 5 | 1318 2002 BLOOD 99(11):4247-4248 Urbauer E; Kaufmann H; Nosslinger T; Raderer M; Drach J Thromboembolic events during treatment with thalidomide | 13 | 18 |
1153 | 4 | 5 | 1401 2002 BRITISH JOURNAL OF HAEMATOLOGY 117(4):996-997 Bauduer F Efficacy of thalidomide in the treatment of VAD-refractory plasma cell leukaemia appearing after autologous stem cell transplantation for multiple myeloma | 0 | 0 |
1154 | 3 | 5 | 1404 2002 BRITISH JOURNAL OF HAEMATOLOGY 119(1):275-275 Pitini V; Teti D; Arrigo C; Aloi G Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF | 0 | 0 |
1155 | 5 | 5 | 1410 2002 BRITISH MEDICAL JOURNAL 325(7374):1245-1245 Ashby J; Tinwell H Thalidomide is not a human mutagen | 0 | 0 |
1156 | 4 | 5 | 1417 2002 CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS 973:414-418 Jin SH; Il Kim T; Han DS; Shin SK; Kim WH Thalidomide suppresses the interleukin 1 beta-induced NF kappa B signaling pathway in colon cancer cells | 1 | 3 |
1157 | 4 | 5 | 1486 2002 JOURNAL OF CLINICAL ONCOLOGY 20(8):2212-2212 Cany L; Fitoussi O; Boiron JM; Marit G Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma | 4 | 4 |
1158 | 3 | 5 | 1525 2002 LEUKEMIA RESEARCH 26(10):965-966 Tsirigotis P; Venetis E; Rontogianni D; Dervenoulas J; Kontopidou F; Apostolidis P Thalidomide in the treatment of myelodysplastic syndrome with fibrosis | 2 | 2 |
1159 | 3 | 5 | 1540 2002 ONCOLOGY-NEW YORK 16(9):1146-+ Leibowitz R; Tucker SJ PSA response to thalidomide in patients with advanced prostate cancer | 0 | 0 |
1160 | 1 | 5 | 1567 2003 AMERICAN JOURNAL OF HEMATOLOGY 74(4):290-291 Gomez-Rangel JD; Ruiz-Delgadoz GJ; Ruiz-Arguelles GJ Pegylated-interferon induced severe bone marrow hypoplasia in a patient with multiple myelorna receiving thalidomide | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1161 | 2 | 5 | 1575 2003 ANNALS OF HEMATOLOGY 82(4):262-262 Ribatti A; Vacca A On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma | 0 | 0 |
1162 | 1 | 5 | 1593 2003 ARCHIVOS DE BRONCONEUMOLOGIA 39(6):286-286 Valero FC Lung toxicity due to thalidomide | 0 | 0 |
1163 | 3 | 5 | 1678 2003 BRITISH JOURNAL OF HAEMATOLOGY 121(1):191-192 Younis TH Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma | 1 | 2 |
1164 | 2 | 5 | 1758 2003 JOURNAL OF PEDIATRICS 143(5):692-694 Yasui K; Misawa Y; Shimizu T; Komiyama A; Kawakami T; Mizoguchi M Thalidomide therapy for juvenile-onset entero-Behcet disease | 0 | 1 |
1165 | 2 | 5 | 1835 2004 AMERICAN JOURNAL OF HEMATOLOGY 75(3):176-177 Jung CP; Emmerich B; Goebel FD; Bogner JR Successful treatment of a patient with HIV-associated multicentric castleman disease (MCD) with thalidomide | 0 | 0 |
1166 | 5 | 5 | 1842 2004 ANNALS OF ONCOLOGY 15(3):537-537 Fuente N; Mane JM; Barcelo R; Munoz A; Perez-Hoyos T; Lopez-Vivanco G Tumor lysis syndrome in a multiple myeloma treated with thalidomide | 0 | 0 |
1167 | 4 | 5 | 1871 2004 BRITISH JOURNAL OF HAEMATOLOGY 125(1):96-97 Fakhouri F; Guerraoui H; Presne C; Peltier J; Delarue R; Muret P; Knebelmann B Thalidomide in patients with multiple myeloma and renal failure | 0 | 0 |
1168 | 2 | 5 | 1942 2004 LANCET 363(9403):169-169 McBride W Health of thalidomide victims and their progeny | 0 | 0 |
1169 | 2 | 5 | 1944 2004 LANCET 363(9424):1911-1911 Crawford CL Does thalidomide have a role in leprosy? | 0 | 0 |
1170 | 5 | 5 | 1960 2004 MEDICAL JOURNAL OF AUSTRALIA 180(7):366-367 Coutsouvelis J; Corallo CE Thalidomide-induced bradycardia and its management | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1171 | 0 | 4 | 39 1982 ARCHIVES OF DERMATOLOGY 118(8):536-536 SAYLAN T; SALTIK I THALIDOMIDE IN THE TREATMENT OF BEHCETS SYNDROME | 42 | 59 |
1172 | 0 | 4 | 62 1983 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 110(6-7):551-552 NOUGUE J; NOUGUE M; BAZEX J; HAYEK JP; BIDOUZE H OCCURRENCE OF A GENITAL HEMORRHAGIC DURING A THALIDOMIDE TREATED PRURIGO NODULARIS | 3 | 3 |
1173 | 2 | 4 | 95 1983 PRESSE MEDICALE 12(47):3007-3007 PRIGENT F; OUAZZANI W SARCOIDOSIS OF THE SKIN - TREATMENT WITH THALIDOMIDE | 4 | 4 |
1174 | 0 | 4 | 121 1984 LANCET 2(8394):98-99 NIELSEN H; BENNIKE T THALIDOMIDE ENHANCES DEFECTIVE MONOCYTE FUNCTION IN LEPROMATOUS LEPROSY | 6 | 8 |
1175 | 1 | 4 | 152 1985 INTERNATIONAL JOURNAL OF DERMATOLOGY 24(9):616-616 AYRES S DISCOID LUPUS-ERYTHEMATOSUS - THALIDOMIDE OR VITAMIN-E | 0 | 1 |
1176 | 0 | 4 | 168 1985 PEDIATRIC RESEARCH 19(4):A324-A324 GARDNER LI; WELSHSLOAN J; CADY RB PHOCOMELIA OF LEFT LOWER LEG IN AN INFANT WHOSE MOTHER TOOK LARGE DOSES OF PYRIDOXINE (B-6) - DEJA VU OF THE THALIDOMIDE DISASTER | 0 | 0 |
1177 | 0 | 4 | 203 1987 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 114(11):1387-1389 GNASSIA AM; GNASSIA RT; BONVALET D; PUISSANT A; GOUDAL H HISTIOCYTOSIS-X WITH VULVAR LOCALIZATION - DRAMATIC EFFECT OF THALIDOMIDE | 15 | 23 |
1178 | 3 | 4 | 234 1988 LANCET 1(8577):117-117 LIM SH; MCWHANNELL A; VORA AJ; BOUGHTON BJ SUCCESSFUL TREATMENT WITH THALIDOMIDE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION | 32 | 35 |
1179 | 1 | 4 | 286 1990 LANCET 335(8705):1591-1591 YOULE M; HAWKINS D; GAZZARD B THALIDOMIDE IN HYPERALGIC PHARYNGEAL ULCERATION OF AIDS | 9 | 11 |
1180 | 2 | 4 | 289 1990 MEDICAL JOURNAL OF AUSTRALIA 152(7):382-383 GEORGHIOU PR; KEMP RJ HIV-ASSOCIATED ESOPHAGEAL ULCERS TREATED WITH THALIDOMIDE | 6 | 9 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1181 | 1 | 4 | 292 1990 PRESSE MEDICALE 19(15):722-722 SAMSON J; KUFFER R; RADEFF B THALIDOMIDE TREATMENT OF CHOICE OF APHTHAE IN HIV-INFECTION | 2 | 2 |
1182 | 1 | 4 | 311 1991 LANCET 337(8738):436-437 WILLIAMS I; WELLER IVD; MALIN A; ANDERSON J; WATERS MFR THALIDOMIDE HYPERSENSITIVITY IN AIDS | 26 | 34 |
1183 | 3 | 4 | 321 1992 GENITOURINARY MEDICINE 68(6):424-425 STRAZZI S; LEBBE C; GEOFFRAY C; ABLON G; MOREL P; VEROLA O; MOLINA JM APHTHOUS ULCERS IN HIV-INFECTED PATIENTS - TREATMENT WITH THALIDOMIDE | 8 | 10 |
1184 | 3 | 4 | 356 1993 BRITISH MEDICAL JOURNAL 307(6909):939-940 BURROWS NP DIAGNOSIS AND MANAGEMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS - THALIDOMIDE MODIFIES DISEASE | 1 | 1 |
1185 | 2 | 4 | 392 1994 BRITISH MEDICAL JOURNAL 308(6944):1635-1636 MCBRIDE WG THALIDOMIDE MAY BE A MUTAGEN | 18 | 24 |
1186 | 4 | 4 | 443 1995 BRITISH JOURNAL OF DERMATOLOGY 132(1):168-168 MEUNIER L; MARCK Y; RIBEYRE C; MEYNADIER J ADULT CUTANEOUS LANGERHANS CELL HISTIOCYTOSIS - REMISSION WITH THALIDOMIDE TREATMENT | 9 | 20 |
1187 | 2 | 4 | 496 1996 AMERICAN JOURNAL OF OPHTHALMOLOGY 122(4):594-595 Ip M; Gorin MB Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide | 4 | 13 |
1188 | 3 | 4 | 618 1997 JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 15(5):392-392 Sharp M; Getty J; Klausner JD Thalidomide use is associated with weight gain in HIV-1-positive clients | 2 | 2 |
1189 | 2 | 4 | 738 1998 PALLIATIVE MEDICINE 12(3):208-209 Deaner P Thalidomide for distressing night sweats in advanced malignant disease | 12 | 13 |
1190 | 4 | 4 | 888 2000 ARCHIVES OF DERMATOLOGY 136(12):1442-1443 Camisa C; Popovsky JL Effective treatment of oral erosive lichen planus with thalidomide | 6 | 11 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1191 | 4 | 4 | 949 2000 BRITISH JOURNAL OF HAEMATOLOGY 110(3):754-754 Gutheil J; Finucane D Thalidomide therapy in refractory solid tumour patients | 10 | 13 |
1192 | 1 | 4 | 1032 2000 NEW ENGLAND JOURNAL OF MEDICINE 342(13):975-976 Barlogie B Thalidomide in multiple myeloma - Reply | 0 | 0 |
1193 | 2 | 4 | 1045 2000 PALLIATIVE MEDICINE 14(5):429-431 Deaner PB The use of thalidomide in the management of severe sweating in patients with advanced malignancy: trial report | 0 | 1 |
1194 | 1 | 4 | 1084 2001 ARTHRITIS AND RHEUMATISM 44(10):2457-2458 Breban M; Dougados M The efficacy of thalidomide in severe refractory seronegative spondylarthropathy: Reply | 2 | 5 |
1195 | 2 | 4 | 1092 2001 BLOOD 97(8):2527-2528 Kyrtsonis MC; Kokoris SI; Kontopidou FN; Siakantaris MP; Kittas C; Pangalis GA Development of a myeloproliferative disorder in a patient with monoclonal gammopathy of undetermined significance secreting immunoglobulin of the M class and treated with thalidomide and anti-CD20 monoclonal antibody | 0 | 1 |
1196 | 4 | 4 | 1144 2001 BONE MARROW TRANSPLANTATION 27(2):229-230 Schlossberg H; Klumpp T; Sabol P; Herman J; Mangan K Severe cutaneous ulceration following treatment with thalidomide for GVHD | 0 | 1 |
1197 | 2 | 4 | 1146 2001 BRITISH JOURNAL OF CANCER 85:25-25 Dalgleish A; Marriott J; Czajka A; Clarke I; Dredge K; Muller G; Stirling D New thalidomide analogues; Anti-cancer, anti-angiogenic and immunostimulatory. | 0 | 0 |
1198 | 4 | 4 | 1150 2001 BRITISH JOURNAL OF DERMATOLOGY 144(6):1292-1293 Passeron T; Lacour JP; Murr D; Ortonne JP Thalidomide-induced amenorrhoea: two cases | 4 | 4 |
1199 | 3 | 4 | 1154 2001 BRITISH JOURNAL OF HAEMATOLOGY 115(1):234-234 Myers B; Grimley C; Crouch D; Dolan G Lack of response to thalidomide in plasmacytomas | 2 | 4 |
1200 | 3 | 4 | 1249 2001 NEW ENGLAND JOURNAL OF MEDICINE 344(25):1951-1952 Osman K; Comenzo R; Rajkumar SV Deep venous thrombosis and thalidomide therapy for multiple myeloma. | 46 | 59 |